Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 7.

Schliessbach, J; Vuilleumier, P H; Siegenthaler, A; Bütikofer, L; Limacher, A; Juni, P; Zeilhofer, H U; Arendt-Nielsen, L; Curatolo, M (2017). Analgesic effect of clobazam in chronic low-back pain but not in experimentally induced pain. European Journal of Pain, 21(8):1336-1345.

Wykrzykowska, J J; Garg, S; Onuma, Y; de Vries, T; Morel, M; van Es, G; Buszman, P; Linke, A; Ischinger, T; Klauss, V; Corti, R; Eberli, F; Wijns, W; Morice, M; Di Mario, C; van Geuns, R; Juni, P; Windecker, S; Serruys, P W (2011). Implantation of the biodegradable polymer biolimus-eluting stent in patients with high SYNTAX score is associated with decreased cardiac mortality compared to a permanent polymer sirolimus-eluting stent: two year follow-up results from the "all-comers" LEADERS trial. EuroIntervention, 7(5):605-13.

Reichenbach, S; Juni, P; Werlen, S; Nüesch, E; Pfirrmann, C W; Trelle, S; Odermatt, A; Hofstetter, W; Ganz, R; Leunig, M (2010). Prevalence of cam-type deformity on hip magnetic resonance imaging in young males: a cross-sectional study. Arthritis Care and Research, 62(9):1319-1327.

Wykrzykowska, J J; Garg, S; Girasis, C; de Vries, T; Morel, M A; van Es, G A; Buszman, P; Linke, A; Ischinger, T; Klauss, V; Corti, R; Eberli, F; Wijns, W; Morice, M C; di Mario, C; van Geuns, R J; Juni, P; Windecker, S; Serruys, P W (2010). Value of the SYNTAX score for risk assessment in the all-comers population of the randomized multicenter LEADERS (Limus Eluted from A Durable versus ERodable Stent coating) trial. Journal of the American College of Cardiology, 56(4):272-277.

Wykrzykowska, J J; Räber, L; de Vries, T; Bressers, M; Buszman, P; Linke, A; Ischinger, T; Klauss, V; Eberli, F; Corti, R; Wijns, W; Morice, M C; di Mario, C; Regar, E; Juni, P; Windecker, S; Serruys, P W (2009). Biolimus-eluting biodegradable polymer versus sirolimus-eluting permanent polymer stent performance in long lesions: results from the LEADERS multicentre trial substudy. EuroIntervention, 5(3):310-317.

Serruys, P W; Wykrzykowska, J J; Onuma, Y; de Vrie, T; Avan Es, G; Buszman, P; Linke, A; Ischinger, T; Klauss, V; Corti, R; Eberli, F; Wijns, W; Moprice, M C; di Mario, C; van Geuns, R J; Juni, P; Windecker, S (2009). Impact of vessel size on angiographic and clinical outcomes of revascularization with biolimus-eluting stent with biodegradable polymer and sirolimus-eluting stent with durable polymer the LEADERS trial substudy. JACC: Cardiovascular Interventions, 2(9):861-870.

Billinger, M; Beutler, J; Taghetchian, K R; Remondino, A; Wenaweser, P; Cook, S; Togni, M; Seiler, C; Stettler, C; Eberli, F R; Lüscher, T F; Wandel, S; Juni, P; Meier, B; Windecker, S (2008). Two-year clinical outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents in diabetic patients. European Heart Journal, 29(6):718-725.

This list was generated on Thu Mar 21 08:46:04 2019 CET.